PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots NewswireSPOTLIGHT INTERVIEW SPOTLIGHTCXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots SPOTLIGHTCXO Talks: Colin Banas from DrFirst in an Illuminating Conversation with PharmaShots SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Michael Bierl SPOTLIGHTReuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer SPOTLIGHTReuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva SPOTLIGHTCXO Talks: Ali Jannati from Linus Health in a Stimulating Dialogue Exchange with PharmaShots SPOTLIGHTReuters Pharma 2025: Pre-Conference Talks Featuring Mike RyanEXCLUSIVE INTERVIEW EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots EXCLUSIVEAdvancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots EXCLUSIVEExclusive: David Esposito in an Illuminating Discussion with PharmaShots EXCLUSIVEExclusive: GeoVax’s CEO David A. Dodd in an Engaging Conversation with PharmaShotsLATEST NEWSStay up-to-date Merck NDA for Investigational HIV-1 Two-Drug Regimen DOR/ISL Accepted by US FDA1 hour ago Moleculin Receives RAMPA’s CTA Approval for P-IIb/III (MIRACLE) Study of AnnAraC in R/R AML2 hours ago AbbVie Enters a Licensing Deal with IGI Therapeutics for ISB 20013 hours ago BeOne Medicines’ Tevimbra Receives the EC Approval for Nasopharyngeal Carcinoma21 hours ago LEO Pharma Reports Interim P-IIIb (ADHAND) Trial Data on Adbry for Atopic Dermatitis22 hours ago Biocytogen Pharmaceuticals Enters a Licensing Agreement with BeOne Medicines for Multiple Antibody Candidates23 hours agoRead More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox.Join the PharmaShots Family of 20000+ subscribersSubscribe NowYoutube VideosStay up-to-dateMore Posts
Moleculin Receives RAMPA’s CTA Approval for P-IIb/III (MIRACLE) Study of AnnAraC in R/R AML2 hours ago
Biocytogen Pharmaceuticals Enters a Licensing Agreement with BeOne Medicines for Multiple Antibody Candidates23 hours ago
